Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

MDVN $105.33 8.3600 +8.62%
PBYI $90.60 6.4700 +7.69%
BDSI $8.15 0.5000 +6.54%
OGXI $3.45 0.2100 +6.48%
TKMR $10.83 0.5800 +5.66%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CTIX $2.57 -0.1400 -5.17%
SNSS $1.40 -0.0750 -5.10%
MNKD $4.29 -0.1700 -3.81%
TLOG $2.35 -0.0900 -3.69%
CCXI $8.24 -0.3000 -3.51%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 888 | 889 | 890 | 891 | 892 | 893 | 894 | 895 | 896 | 897 | Next > | Last >>

Men at Higher Risk for 32 out of 35 Cancers

(San Francisco Chronicle) Jan 18, 2012 - In an article published this month in the online version of the European Journal of Epidemiology, a group of American and Swedish researchers, including the Cancer Prevention Institute of California (CPIC), present the results of a worldwide study that found that for 32 out of 35 cancers, men are at higher risk.
read article 

Cancer Detecting Dye Could ‘Save Many Lives’

(Cambridge First) Jan 17, 2012 - A fluorescent dye that pinpoints the tiniest sign of cancer when sprayed onto the oesophagus (the food pipe) could detect the disease earlier - potentially saving many lives, Cambridge scientists have discovered.
read article 

Study Reveals Origins of Esophageal Cancer

(CUMC) Jan 17, 2012 - Researchers at Columbia University Medical Center (CUMC) have identified the critical early cellular and molecular events that give rise to a type of esophageal cancer called esophageal adenocarcinoma, the fastest-rising solid tumor in the United States.
read press release 

Moving the Pancreas Cancer Specialty Forward: When Tissue is the Issue

(GI Cancer Symposium Daily News/ASCO) Jan 18, 2012 - Progress in improving the long-term outcome for patients with pancreatic ductal adenocarcinoma (PDAC) has been painfully slow.
read article 

Progress in the Management of Upper Gastrointestinal Malignancies

(GI Cancer Symposium Daily News/ASCO) Jan 18, 2012 - Cancers of the upper gastrointestinal tract form a heterogeneous group of diseases for which treatment paradigms for localized disease continue to emerge. Recently, several phase III studies in esophagus and gastric cancers that have attempted to define new standards of care have been reported.
read article 

Liver Transplantation: an Essential Component of Treatment Paradigms for Hepatobiliary Malignancy

(GI Cancer Symposium Daily News/ASCO) Jan 18, 2012 - Hepatocellular carcinoma (HCC) is an important cancer that can be successfully treated by removal of the tumor or of the liver.
read article 

Re-examining the Surgical Variable in Multimodality Clinical Trials for Gastric Cancer

(GI Cancer Symposium Daily News/ASCO) Jan 18, 2012 - Progress in the design and conduct of clinical trials of adjuvant therapy in patients with gastric cancer has been slow because of complex variables including tumor location, histology, different therapeutic modalities, and variability of surgical technique.
read article 

Targeting Glucose Metabolism: A New Class of Agents against Liver Cancer

(GI Cancer Symposium Daily News/ASCO) Jan 18, 2012 - Hepatocellular carcinoma (HCC) is one of the most highly lethal malignancies in the world making it the third most common cause of cancer related mortality worldwide.
read article 

Gastric Cancer: Finding the Optimal Approach to Adjuvant Therapy

(GI Cancer Symposium Daily News/ASCO) Jan 18, 2012 - In 2011 gastric cancer is estimated to afflict nearly 21,500 people in the United States, resulting in 10,000 deaths.
read article 

Aspirin for the Prevention of Colorectal Cancer: Weighing Benefits against Risks

(GI Cancer Symposium Daily News/ASCO) Jan 18, 2012 - Despite increasing efforts in many countries to reduce the incidence of colorectal cancer (CRC) through population-based screening, more than 600,000 men and women worldwide die of CRC each year.
read article 

Consolidating Treatment Response Following Completion of Systemic Therapy in Patients with Oligometastatic Colorectal Cancer

(GI Cancer Symposium Daily News/ASCO) Jan 18, 2012 - Surgical resection with curative intent remains the standard of care for patients with oligometastatic colorectal cancer to the liver and lungs; however, only 10% to 25% of such patients are suitable for initial surgical intervention.
read article 

Blood Test Shows Promise in Spotting Pancreatic Cancers Early

(MSN Health/HealthDay News ) Jan 17, 2012 - A new blood test may hold promise as a means of early detection and diagnosis for often deadly pancreatic cancers.
read article 

FDA Approves BTG's Drug for Cancer Toxicity

(Reuters) Jan 17, 2012 - U.S. health regulators gave the nod on Tuesday to a drug from British specialty drugmaker BTG Plc that helps cancer patients get rid of toxic levels of a chemotherapy treatment.
read article 

Myriad Genetics Gets Rights to Cancer-Linked Gene

(Yahoo! Finance/Associated Press) Jan 18, 2012 - Myriad Genetics Inc. said Wednesday that it has acquired the rights to a gene that, when mutated, is associated with increased risk for hereditary breast and ovarian cancer.
read article 

2012 Gastrointestinal Cancers Symposium Reveals New Advances Aimed at Improving Treatment, Prognosis and Detection of GI Cancers

(ASCO) Jan 17, 2012 - New research into the treatment, prognosis and early detection of gastrointestinal cancers was released today in advance of the ninth annual Gastrointestinal Cancers Symposium being held January 19-21, 2012, at The Moscone West Building in San Francisco, Calif.
read press release 

Bayer Colon Cancer Drug Regorafenib Extended Lives 29%, Halted Study Shows

(Bloomberg) Jan 17, 2012 - Bayer AG said its cancer medicine regorafenib improved survival for people with advanced colon cancer by 29 percent, fleshing out details of a trial halted last year in order to give all the participants the new drug.
read article 

Clinics Offer Beauty Tricks to Help Cancer Patients

(USA Today/The Tennessean) Jan 16, 2012 - Makeup blankets a table like a beauty banquet, and a dozen women on a lunch date devour it with delight.
read article 

A Doctor in Your Pocket

(Wall Street Journal) Jan 14, 2012 - What does the future of medicine hold? Tiny health monitors, tailored therapies—and the end of illness.
read article (paid subscription required) 

Medivation, Pfizer Alzheimer's Drug Fails to Meet Study Goals

(Wall Street Journal) Jan 17, 2012 - Pfizer and Medivation are ending the development of a potential Alzheimer's treatment after the drug yielded disappointing results in a late-stage clinical study.
read article (paid subscription required) 

FDA Would Collect Millions in Fees to Speed Review of Traditional and Biotech Generic Drugs

(Washington Post/Associated Press) Jan 13, 2012 - The Food and Drug Administration would collect hundreds of millions of dollars in new fees from pharmaceutical companies to help speed up the review of generic drugs, under an agreement with industry released by the agency on Friday.
read article (free registration required) 

U.S. to Force Drug Firms to Report Money Paid to Doctors

(New York Times) Jan 16, 2012 - To head off medical conflicts of interest, the Obama administration is poised to require drug companies to disclose the payments they make to doctors for research, consulting, speaking, travel and entertainment.
read article 

Dr. Constance A. "Connie" Griffin

(Baltimore Sun) Jan 13, 2012 - Dr. Constance A. "Connie" Griffin, an internationally known pancreatic cancer researcher who led the Johns Hopkins Kimmel Cancer Center's Cytogenetics Core and was director of the Pathology Molecular Diagnostics Laboratory, died Jan. 8 of pancreatic cancer at Johns Hopkins Hospital.
read article 

Neighborhood Cancer Care

(Boston Globe) Jan 15, 2012 - Cancer treatment centers with links to the most prestigious hospitals in the state are springing up in suburban communities, a trend that experts say will allow area residents to receive top-notch care close to home at a time when more people face a greater chance of developing the disease.
read article (free registration required) 

After Urologists Got Machine, Cancer Treatments Soared

(Baltimore Sun) Jan 17, 2012 - Four years ago, doctors at Chesapeake Urology Associates started ordering the most expensive kind of prostate-cancer therapy for many more of their patients.
read article 

Physicians Can Find Themselves in the Middle of Medical Guideline Debates

(AMed News/Ethics Forum) Jan 16, 2012 - Scenario: How do we explain conflicting screening guidelines? The U.S. Preventive Services Screening Task Force, specialty societies and disease advocacy groups promulgate guidelines for prevention of illness and disease. Sometimes screening recommendations from different groups -- for the same condition -- are not in sync.
read article